Fisher & Paykel Healthcare Corporation Limited (NZSX:FPH, ASX:FPH) is hosting a technical briefing session for analysts and investors today.
During the session the company will be discussing the clinical applications of its medical devices, its product technologies and its multiple distribution channels.
The company will provide a preview of its new flow generator product range for the treatment of obstructive sleep apnea, which will be introduced later this financial year. The new product range features a very compact design and will include models which incorporate combinations of the company’s innovative technologies, including SensAwake, Auto pressure setting, ThermoSmart and SmartStick.
A copy of the technical briefing presentation is available on request from the company by emailing:
glenda.jones@fphcare.co.nz.
About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea. The company’s products are sold in over 120 countries worldwide. For more information about the company visit www.fphcare.com.
Contact: Michael Daniell MD/CEO on +64 9 574 0161 or Tony Barclay CFO on +64 9 574 0119.
About Fisher & Paykel Healthcare
Fisher & Paykel Fisher Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in more than 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.
Ends
Contact
|